Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service — Maria Cristina Vedovati (2022) | RDL Network
Despite the recent advancements, oral anticoagulation is still challenging in some patients and this is the case for old and frail patients. The large majority of frail patients with atrial fibrillation should receive anticoagulation since the associated benefits outweigh the risk of bleeding. A multidisciplinary consensus document on the use and prescription of direct oral anticoagulants (DOACs) in older and frail patients with atrial fibrillation has been recently published. In this manuscript we provide a comment on this document and add insights into the management of these patients. The new DOAC age had imposed a paradigm shift in the management of patients with the need for clinically-oriented services rather than laboratory-oriented services. In this paper we provide tools for a structured patient-oriented DOACs treatment service supported by a multidisciplinary approach.
David Seiffge, Maurizio Paciaroni, Duncan Wilson, Masatoshi Koga, Kosmas Macha, Manuel Cappellari, Sabine Schaedelin, Clare Shakeshaft, Masahito Takagi, Georgios Tsivgoulis, Bruno Bonetti, Bernd Kallmünzer, Shoji Arihiro, Andrea Alberti, Alexandros A. Polymeris, Gareth Ambler, Sohei Yoshimura, Michele Venti, Leo H. Bonati, Keith W. Muir, Hiroshi Yamagami, Sebastian Thilemann, Riccardo Altavilla, Nils Peters, Manabu Inoue, Tobias Bobinger, Giancarlo Agnelli, Martin M. Brown, Shoichiro Sato, Monica Acciarresi, Hans Rolf Jäger, Paolo Bovi, Stefan Schwab, Philippe Lyrer, Valeria Caso, Ḱazunori Toyoda, David J. Werring, Stefan T. Engelter, Gian Marco De Marchis
María Asunción Esteve‐Pastor, José Miguel Rivera‐Caravaca, Martín Ruiz Ortiz, Javier Muñiz, Inmaculada Roldán‐Rabadán, Déborah Otero, Raquel López‐Gálvez, Ángel Cequier, Vicente Bertoméu, Lina Badimón, Manuel Anguita, Professor Gregory Lip, Francisco Marı́n
Discussion(0)
No comments yet. Be the first to comment.